Analysis of several public datasets corroborated our findings, indicating that prostate cancer patients with higher HNRNPA1 levels experienced quicker disease relapse and metastasis47,59 (Fig. 4k and Supplementary Fig. 4l). The gene discussed is HNRNPA1; the disease is prostate carcinoma.